EURX Eurand N.V. (MM)

Event:         Stifel Nicolaus Healthcare Conference
Date:          Thursday, September 16, 2010
Time:          10:20 a.m. ET
Location:      Four Seasons Hotel
               200 Boylston Street
               Boston, Mass.
Speaker:       Gearóid Faherty, Chairman and Chief Executive Officer

Event:         UBS Global Life Sciences Conference
Date:          Monday, September 20, 2010
Time:          9:00 a.m. ET
Location:      Grand Hyatt Hotel
               Park Avenue at Grand Central
               New York, N.Y.
Speaker:       John Fraher, Chief Commercial Officer

An audio webcast of the Company's presentations at each conference will be available by accessing the investor relations section of www.eurand.com and will be available via replay for 30 days following the date of the presentation.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.

Contacts: Bill Newbould Vice President, Investor Relations Eurand N.V. +1-267-759-9335 Email Contact Nick Laudico/Sara Pellegrino The Ruth Group +1-646-536-7030/7002 Email Contact Email Contact

Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Jul 2023 to Jul 2024